Scalable preparation of osteogenic micro‐tissues derived from hESC‐derived immunity‐and‐matrix‐regulatory cells within porous microcarriers in suspension culture

Bone defects (BDs), a prevalent clinically refractory orthopaedic disease, presently have no effective treatments. Mesenchymal stem cells (MSCs) can differentiate into osteoblasts and serve as potential seed cells for bone tissue engineering for BD treatment. However, the feasibility of using MSCs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Huike, Gao, Tingting, Wang, Liu, Mohsin, Ali, Hao, Jie, Guo, Meijin, Wu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212705/
https://www.ncbi.nlm.nih.gov/pubmed/37199065
http://dx.doi.org/10.1111/cpr.13466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212705/
https://www.ncbi.nlm.nih.gov/pubmed/37199065
http://dx.doi.org/10.1111/cpr.13466

Ejemplares similares